If you are looking into peptides for healing after a strain, an injury or a sore joint, the short answer is this: six peptides now in the news have a narrow, conditional route to being compounded in the US under a new HHS policy. That is enforcement discretion, and it is not FDA approval. According to AP reporting, most of the data on peptides comes from animal studies, and FDA staff said none of the six had been studied enough to establish safety and effectiveness. Below you will find what each peptide is, what it is said to do, the risks, and the checks to make before you pay anyone.
Quick facts, checked 2026-11-02
| Fact | Detail | Where it comes from |
|---|---|---|
| Which peptides are covered | BPC-157, TB-500, Epitalon, Semax, KPV and MOTS-c, each in one listed form | HHS Federal Register notice |
| Who the policy covers | Qualifying 503A pharmacies and physician compounders. 503B outsourcing facilities are not covered. | LegitScript’s policy summary |
| Prescription needed | Yes, a patient-specific prescription | LegitScript’s policy summary |
| What is excluded | Products sold as research chemicals or dietary supplements | BakerHostetler law firm summary |
| Can it change | Yes, HHS may revise or withdraw the policy in whole or in part if a safety signal or product quality issue arises | HHS policy document |
| Public comments close | November 13, 2026 | HHS Federal Register notice |
| Required label text | “This is a compounded drug product. Not for resale.” | LegitScript’s policy summary |
| Certification review update | Effective November 2, 2026. LegitScript says certification does not guarantee advertising or payment access. | LegitScript’s policy summary |
What is the new peptide policy, and what does it not do?
Peptides are strings of amino acids, smaller than a protein. ABC News notes that some peptides, such as insulin and GLP-1s, are FDA-approved medicines that have been rigorously tested. The six in this policy are a different category. HHS states that “Compounded drugs are not FDA-approved, which means FDA does not review their safety, effectiveness, or quality before they are marketed.”
On October 30, 2026, HHS published its interim policy. It says it “does not intend to take enforcement action” against qualifying compounders under the conditions it lists, and it covers BPC-157, TB-500, Epitalon, Semax, KPV and MOTS-c. Each is limited to one listed form and to specific routes. HHS also says compounded drugs “can serve an important medical need for certain patients,” but “also may pose risks to patients.”
The policy does not add these peptides to FDA’s 503A bulks list, and it does not remove other legal requirements, according to LegitScript’s summary of the policy. It does not reach 503B outsourcing facilities, or products sold as research chemicals or dietary supplements, according to the BakerHostetler summary.
Some background helps. HHS’s appendix says FDA’s drug center recommended against listing these six, and an advisory committee voted in favor in July. Before that, each had been in FDA’s Category 2, where bulk substances “may present significant safety risks,” from September 2023 until April 22, 2026. The FDA’s list of risky bulk substances shows that category. For the difference between the two compounding pathways, the 503A and 503B explainer notes that 503A pharmacies are “regulated by the states, typically retail and hospital pharmacies,” while outsourcing facilities must meet additional requirements.
Who might fit, and who should pause?
Under the policy, the route runs through a licensed prescriber who writes a prescription for you as an individual, and a pharmacy that meets its conditions. For most people that means a conversation with a prescriber first, before any product page.
Talk to a prescriber before any injection if you have had allergic reactions before. The FDA lists allergic reactions among the risks, as AP reports. If your injury is getting worse, or you have new numbness, weakness or swelling, see a clinician before you try anything, peptide or not.
What is each peptide, and what are they said to do?
This table lists the six peptides, the routes the policy allows, and what the sources say about each one.
| Peptide | Routes the policy lists | What the sources say |
|---|---|---|
| BPC-157 acetate | Subcutaneous, intramuscular, oral, topical | AP describes it as a chemical “promoted to build muscle” and for injuries. A Miami clinic says it has been studied for repair of muscles, tendons and ligaments. |
| TB-500 acetate | Subcutaneous, intramuscular | The Miami clinic says TB-500 “may support tissue regeneration and help improve flexibility.” |
| Epitalon acetate | Subcutaneous, intramuscular | Listed in the policy’s Appendix A with the other five. |
| Semax free base | Intranasal | Listed in the policy’s Appendix A with the other five. |
| KPV acetate | Topical, oral | Oral use also needs documentation that the specific formulation achieves adequate oral bioavailability in humans, according to LegitScript. |
| MOTS-c acetate | Subcutaneous, intramuscular | Listed in the policy’s Appendix A with the other five. |
The Miami clinic’s recovery peptides page also lists GHK-Cu among recovery peptides. GHK-Cu is not one of the six in this policy.
Does BPC-157 need to be injected near the injury?
The policy allows BPC-157 by four routes: subcutaneous, intramuscular, oral and topical. Where a shot goes and which route fits your problem is a decision for your prescriber, so bring the question to them.
BPC-157 and TB-500 together
LegitScript reads the policy’s single-ingredient condition as excluding combinations with any other active ingredient. It says combinations such as BPC-157 with TB-500 do not meet that requirement. A blend is therefore outside the policy’s coverage under LegitScript’s reading.
What does BPC-157 do to your body, and how is it said to work?
A Miami clinic that offers recovery peptides describes them as “short chains of amino acids that may signal the body to support tissue repair, inflammation control, collagen production, and circulation during healing.” The clinic says recovery peptides “work by attaching to specific cell receptors, triggering signals that activate the body’s repair and growth functions.” That is the clinic’s account, not a finding from a trial. For how inflammation fits into these claims, see our guide to peptides and inflammation.
The same clinic states that BPC-157 and TB-500 “are not FDA-approved for human therapeutic use and may be considered investigational or off-label.” That line matters for your decision.
Do peptides actually help with recovery?
FDA staff cited a lack of solid clinical trial data for these peptides (ABC News), and AP reports that most of the data on peptides comes from animal studies. So whether these six peptides help recovery in people is not established. Here is what the regulators and the studies say.
What did the FDA’s review find?
According to AP, FDA’s staff scientists reiterated that “none of the peptides had been studied enough to establish their safety and effectiveness.” The Hill, reporting on FDA briefing materials, says staff reached the same conclusion for all six. For BPC-157 in ulcerative colitis, staff said there was a lack of data to conclude it is effective. The July advisory vote went the other way, and the two are not the same thing. ABC News on the July vote reports the committee voted narrowly, and that its recommendations are not binding.
What do the studies cover?
AP reports that most of the data on peptides comes from animal studies. The published research you may find is also often broader than these six. A 2016 antimicrobial peptides review in Experimental Dermatology covers antimicrobial peptides, which the body makes itself, and describes “promising therapeutic potential” for skin and epithelial injuries. It is a review, not a trial of the six peptides. A 2019 amphibian skin peptide review covers wound healing in amphibians, not people.
What was studied in people?
ABC News reports that FDA staff cited “a lack of solid clinical trial data” for these peptides. Ask your prescriber which human studies, if any, support the specific peptide they are considering for you. For how to read these studies, see peptides human studies (our research library).
What are the side effects and downsides?
| Concern | What the source says | Where it comes from |
|---|---|---|
| Contamination, allergic reactions and tumor growth | “Possible risks include contamination, allergic reactions and tumor growth, according to the FDA.” | AP report |
| Batch-to-batch differences | FDA staff cited “inconsistent recipes from batch to batch” | ABC News |
| Immune reactions | Staff warned of “the risk the compounds could trigger harmful immune reactions” | ABC News |
| Common side effects listed by a clinic | “nausea, fatigue, dizziness, allergic reactions, or localized redness and swelling at the injection site” | Miami clinic’s recovery peptides page |
| Less monitoring than approved drugs | These custom-mixed products “still skip key protections that come with standard FDA-approved drugs, including ongoing tracking of dangerous side effects and clear safety labeling.” | ABC News |
| Past compounding harm | A 2012 fungal meningitis outbreak from contaminated injectables made by a State-licensed compounding pharmacy caused “more than 60 deaths and 750 cases of infection.” | 2018 Federal Register notice |
What about muscle growth, weight loss and celebrity use?
AP says the uses people buy these for, such as bulking up, looking younger or boosting energy, “are not approved by the Food and Drug Administration.” The Hill reports that the July vote covered uses such as insomnia, obesity and wound healing. The policy lists the six together and does not rank them, so no single one is named the best for muscle growth.
On celebrities, AP says some peptides have been “widely promoted by wellness influencers and fitness celebrities,” and that “Some of the biggest MAHA figures sell peptide injections and supplements.” What a public figure says they take tells you little about whether a peptide fits your injury or your prescriber’s plan. Check the source of any name you see attached to a product.
What does it cost, and what is the total commitment?
Prices and bundles change, so check today’s price directly with the pharmacy or prescriber. Ask for one quote that covers the visit, the prescription and the medicine. Ask whether refills or renewals are part of the order, and ask for the refund and cancellation terms in writing before you pay.
Is the seller legit, and how do you check?
The policy’s route runs from a licensed prescriber to a qualifying pharmacy, not from a product page. Start there.
- Check the pharmacy’s license for your state. The Partnership for Safe Medicines filed a Partnership for Safe Medicines petition saying it bought five vials of unapproved peptides from telehealth services in the past 45 days. The products came from pharmacies licensed in Texas and Pennsylvania, and none of the businesses had the appropriate licenses to dispense injectables in California. A Buchanan Ingersoll & Rooney analysis adds that state boards generally oversee the day-to-day practice of state-licensed pharmacies, while FDA retains inspection and enforcement authority.
- Look up the pharmacy on FDA’s inspection list. The FDA compounding inspections and recalls page lists inspection and warning letter history by facility.
- Ask for the certificate of analysis. The policy requires a valid COA from a facility registered under section 510, and the original manufacturer’s physical location must appear on the COA. The original manufacturer must be FDA-registered. For how to read a COA, see peptide coa explained.
- Read the label. The policy requires: “This is a compounded drug product. Not for resale.”
- Check the device. The policy limits delivery devices to an FDA 510(k)-cleared syringe. LegitScript says clearance of another device, such as an injector pen, does not satisfy this condition.
- Watch the marketing. LegitScript’s LegitScript’s promotion warning signs list claims that a peptide “repairs” a specific condition, and “clinically proven” or “scientifically backed” without disclosure that most research hasn’t been conducted in humans.
- Do not treat a certification as a quality check. LegitScript says its certification “does not guarantee” access to advertising or payment services, and platforms set their own rules.
Some peptides are sold outside any prescription. ABC News describes many people buying from overseas sellers as unregulated “research chemicals,” with “no guarantee of what’s in the vial.” AP reports that these products “remain widely available for purchase via online platforms like TikTok.” Products sold that way are excluded from the policy.
Big telehealth names are also moving in. AP reports that Hims & Hers and Noom each announced plans to offer peptides to customers if federal access eases. Run the same checks on any seller, large or small.
Which questions settle it?
| Question | What a yes or no means |
|---|---|
| Is the peptide one of the six in the policy? | Yes: it may fall within the policy’s conditions. No: the policy does not cover it, and LegitScript says offering other peptides outside the policy remains a barrier to certification. |
| Is the product a single ingredient, not a blend? | Yes: it can meet the single-ingredient condition. No: under LegitScript’s reading, it falls outside the policy. |
| Is the route one the policy lists for that peptide? | Yes: the route is in scope. No: the route is outside the policy. |
| Is a licensed prescriber writing a prescription for you specifically? | Yes: this meets the patient-specific prescription condition. No: the policy’s prescription condition is not met. |
| Is the pharmacy a 503A pharmacy or physician compounder, not a 503B facility? | 503A: may qualify. 503B: not covered by the policy. |
| Is it sold as a research chemical or supplement? | Yes: it is excluded from the policy. |
| Does the COA come from a section 510-registered facility and name the manufacturing location? | Yes: the COA condition is met. No: ask the pharmacy before you pay. |
| Does the label read “This is a compounded drug product. Not for resale.”? | Yes: the label condition is met. No: ask why before you pay. |
| Does the vial come with an FDA 510(k)-cleared syringe? | Yes: the device condition is met. No, or an injector pen instead: that does not satisfy the condition, per LegitScript. |
| Does the pharmacy hold a license in your state? | Yes: confirm it with your state board. No: the Partnership for Safe Medicines findings show why this matters. |
| Does the seller say the peptide repairs a condition, or call it clinically proven? | Yes: LegitScript lists these as signs that content has crossed into promotion. No: those flagged claims are absent. |
What are the approved options, and what about doing nothing?
Some peptide medicines are approved. ABC News reports: “Some — like insulin and GLP-1s — are FDA-approved medicines that have been rigorously tested.” The Hill notes that pharmaceutical companies have brought several peptide drugs to market, including insulin. Ask your prescriber whether an approved medicine is an option for your problem.
For the movement and hands-on side of healing, our guides on the science of healing and the power of manual therapy cover routines that sit alongside any medicine decision.
You can also decide against any peptide. Your prescriber can plan your care around movement and the options above.
How do you verify a seller before you pay?
- Ask for the prescription and confirm the prescriber is licensed in your state.
- Confirm the pharmacy’s state license and check its name on FDA’s inspection and recall page.
- Ask for the COA and confirm it names the original manufacturer’s physical location.
- Check the label text, the single ingredient, the syringe and, for oral products, the bioavailability documentation.
- Get the refund, renewal and cancellation terms in writing.
- Check the Federal Register for changes to the policy after November 13, 2026.
Questions to bring to your prescriber
- Which of the six, if any, do you think fits my problem, and why?
- Which route do you use, and is it one the policy covers?
- Which human studies support this peptide for my use?
- Does my history of allergic reactions change the plan?
- How will side effects be tracked, and who do I contact if one happens?
- Which pharmacy will fill it, and is that pharmacy licensed in my state?
- Are approved medicines or a movement plan worth comparing first?
By The Nerve & Joint Pain Desk Editorial Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.
Keep reading